$1.84
0.08[4.55%]
At close: Apr 17
$1.84
0[0.00%]
After Hours: 9:24AM EDT
CytomX Therapeutics
(NASDAQ:CTMX)CytomX Therapeutics Stock (NASDAQ:CTMX), Earnings Estimates, EPS, and Revenue
CytomX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$21.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$101.2M
Analyze the earnings history of CytomX Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | CTMX | Q1 | -$0.05 | -$0.07 | — | — | $23.50M | $21.28M | — | — | Get Alert |
| 03/11/2024 | PM | CTMX | Q4 | -$0.42 | -$0.03 | $0.01 | 133.33% | $946.00K | $21.04M | $26.61M | 26.46% | Get Alert |
| 11/07/2023 | PM | CTMX | Q3 | -$0.35 | -$0.19 | $0.04 | 121.05% | $16.91M | $14.14M | $26.38M | 86.59% | Get Alert |
| 08/08/2023 | PM | CTMX | Q2 | -$0.45 | -$0.20 | -$0.02 | 90.00% | $12.85M | $13.88M | $24.72M | 78.13% | Get Alert |
| 05/09/2023 | PM | CTMX | Q1 | -$0.37 | -$0.11 | -$0.05 | 54.55% | $17.14M | $19.59M | $23.50M | 19.95% | Get Alert |
| 03/27/2023 | PM | CTMX | Q4 | -$0.40 | -$0.24 | -$0.42 | -75.00% | $19.73M | $17.85M | $946.00K | -94.70% | Get Alert |
| 11/08/2022 | PM | CTMX | Q3 | -$0.35 | -$0.31 | -$0.35 | -12.90% | $17.59M | $17.94M | $16.91M | -5.71% | Get Alert |
| 08/04/2022 | PM | CTMX | Q2 | -$0.30 | -$0.36 | -$0.37 | -2.78% | $16.29M | $17.90M | $18.16M | 1.48% | Get Alert |
| 05/05/2022 | PM | CTMX | Q1 | -$0.26 | -$0.36 | -$0.37 | -2.78% | $15.97M | $20.66M | $17.14M | -17.06% | Get Alert |
| 03/01/2022 | PM | CTMX | Q4 | -$0.31 | -$0.28 | -$0.40 | -42.86% | $16.37M | $24.51M | $19.73M | -19.51% | Get Alert |
| 11/04/2021 | PM | CTMX | Q3 | -$0.32 | -$0.31 | -$0.35 | -12.90% | $17.79M | $18.08M | $17.59M | -2.73% | Get Alert |
| 08/05/2021 | PM | CTMX | Q2 | -$0.34 | -$0.32 | -$0.30 | 6.25% | $16.61M | $16.86M | $16.29M | -3.39% | Get Alert |
| 05/06/2021 | PM | CTMX | Q1 | $0.26 | -$0.35 | -$0.26 | 25.71% | $49.59M | $15.43M | $15.97M | 3.51% | Get Alert |
| 02/24/2021 | PM | CTMX | Q4 | -$0.79 | -$0.50 | -$0.31 | 38.00% | $8.28M | $15.41M | $16.37M | 6.25% | Get Alert |
| 11/05/2020 | PM | CTMX | Q3 | -$0.52 | -$0.48 | -$0.32 | 33.33% | $10.71M | $16.34M | $17.79M | 8.86% | Get Alert |
| 08/06/2020 | PM | CTMX | Q2 | -$0.64 | $0.16 | -$0.34 | -312.50% | $9.01M | $48.21M | $16.61M | -65.55% | Get Alert |
| 05/07/2020 | PM | CTMX | Q1 | -$0.31 | -$0.46 | $0.26 | 156.52% | $29.48M | $19.88M | $49.59M | 149.46% | Get Alert |
| 02/27/2020 | PM | CTMX | Q4 | -$0.74 | -$0.47 | -$0.79 | -68.09% | $11.47M | $17.44M | $8.28M | -52.53% | Get Alert |
| 11/07/2019 | PM | CTMX | Q3 | -$0.53 | -$0.51 | -$0.52 | -1.96% | $12.51M | $18.06M | $10.71M | -40.69% | Get Alert |
FAQ
When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?
CytomX Therapeutics (CTMX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 11, 2024 for Q4.
What were the latest earnings per share (EPS) for CytomX Therapeutics (NASDAQ:CTMX)?
The Actual EPS was $0.01, which beat the estimate of $-0.03.
What were CytomX Therapeutics’s (NASDAQ:CTMX) revenues?
The Actual Revenue was $26.6M, which beat the estimate of $21M.
Browse earnings estimates, EPS, and revenue on all stocks.